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re-antibiotic era of the early 20th century, phage therapy was
ecoming a powerful weapon against infectious diseases of bac-
erial etiology. Unfortunately, phage treatment and research was
argely forgotten in theWesternworldas antibioticsbecamewidely
vailable. Nowadays, the rapid propagation of multi-drug resistant
acterial strains is leading to renewed interest in phage therapy.
Methods: In contrast to its decline in the West, phage ther-
py remained a standard part of the healthcare systems in Eastern
urope and the USSR during the second half of the 20th cen-
ury. Phage preparations were used for diagnostic, therapeutic and
rophylactic purposes to combat various bacterial infections. The
liava Institute of Bacteriophages,Microbiology and Virology (Tbil-
si, Georgia) has been focused on the study of bacteriophages for
any years, particularly the isolation and selection of phages active
gainst various bacterial pathogens, including the most dangerous
acteria.
Results: Bacteriophages have a number of advantages in com-
arison to antibiotics. They are safe, very speciﬁc and do not affect
ormal microﬂora. Today, many patients from various parts of the
orld express their willingness to take phage treatment against
ifferent infections, including those that are caused by antibiotic-
esistant bacterial pathogens. Phage preparations are used to treat
ocal infections (i.e. throat, eye, and ear), infectious wounds and
urns, urinary, respiratory and intestinal tracts infections
Conclusion: Phage therapy as an alternative approach for treat-
ent of infections has reemerged as an evident and promising
emedy. Currently, the Eliava Institute is developing new phage-
ased products and technological schemes for phage production.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.630
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mpact of inappropriate empiric antimicrobial therapy on mor-
ality of septic patients with bacteremia: a retrospective study
. Leuangarun1,∗, A. Leelarasamee2
Chulaborn Hospital, Bangkok, Thailand
Faculty of Medicine Siriraj Hospital, Bangkok, Thailand
Background: Inappropriate empiric antimicrobial therapy
ould lead to unfavorablemortality rate in co-morbid patients. This
tudy aimed to assess the impact of inappropriate antimicrobial on
he mortality of septic patients with bacteremia in a Thai tertiary
ospital.
Methods: A retrospective study was employed in bacteremic
atients with sepsis, severe sepsis, or septic shocks during 2009
t Siriraj Hospital. Demographic data, antimicrobial use and the
rst-dose timing, type of bacteria isolated from blood and their
usceptibilities, 28-day and overall mortality rate were collected
nd analyzed. Inappropriate antimicrobial was deﬁned by the non-
usceptibility of the isolated bacteria to the ﬁrst-dose empiric
ntimicrobial or at 24 hours after the ﬁrst dose.
Results: There were 229 patients with mean age (SD) of 63.5
17.2) years. The mean (SD) APACHE II score was 24.7 (6.8), of
hich 99.1% had at least one co-morbidity. The ﬁrst-dose and 24-
our inappropriate antimicrobial was found in 29.7% and 25.3%,
espectively. The28-day andoverallmortality between inappropri-
te and appropriate antimicrobial were 67.6% vs 60.2% (p=0.301)fectious Diseases 16S (2012) e317–e473
and 75.0% vs 68.3% (p=0.345), subsequently. In patients with sep-
tic shock, inappropriate antimicrobial use signiﬁcantly had higher
28-day mortality than the appropriate antimicrobial use (61.6%
vs 41.9%; p=0.017). Inappropriate ﬁrst-dose antimicrobial was
noticed in64.7%and62.2%among thedrug-resistantGram-positive
and Gram-negative bacteremia. The golden period of appropriate
antimicrobial was less than 3 hours after diagnosis (OR 1.08-1.92,
95% CI 1.08-3.42). From multivariate analysis, inappropriate ﬁrst-
dose antimicrobial (OR 2.52), the ﬁrst-dose timing over 3 hours
(OR 1.8), APACHE II score > 25 (OR 1.66), serum albumin < 3.2 g/dl
(OR 2.52), and septic shock (OR 1.93) were associated with over-
all mortality. Factors related to inappropriate antimicrobial were
nosocomial infections (OR 3.31), leukopenia (OR 2.45) and drug-
resistant gram-positive (OR 6.03) and gram-negative organisms
(OR 10.76).
Conclusion: Inappropriate antimicrobial was discovered in
29.7% of the bacteremic patients with 6.7% excess mortality and
signiﬁcantly higher in the patients with septic shock (19.7%).
Nosocomial infections, leukopenia and drug-resistant organisms
were factors of inappropriate antimicrobial. Appropriate antimi-
crobial over 3 hours increased mortality rate to 13.5%. Hence, the
importance of early appropriate empirical antimicrobial should be
ratiﬁed.
http://dx.doi.org/10.1016/j.ijid.2012.05.631
Type: Poster Presentation
Final Abstract Number: 56.084
Session: Antibiotics
Date: Saturday, June 16, 2012
Time: 12:45-14:15
Room: Poster & Exhibition Area
Amultidisciplinaryapproach toantimicrobial stewardship: tak-
ing advantage of information systems technology
H. Liu1,∗, L. Cushinotto2, H. Mutneja3, H. Williams4
1 Bryn Mawr Hospital, Bala Cynwyd, PA, USA
2 Bryn Mawr Hospital, Bala Cynwyd, PA, USA
3 Maulana Azad Medical College, Delhi, India
4 Bryn Mawr Hospital, Bryn Mawr, PA, USA
Background: Antimicrobial resistance has been increasing in
hospital and community-acquired pathogens; few new antimi-
crobials are on the horizon. Stewardship programs (SP) optimize
antimicrobial use and have the potential to prolong efﬁcacy of
current agents as well as improve quality and cost-effectiveness.
However, case review and correlation of diagnoses, antimicrobial
dosing, allergies, and microbiologic data, and monitoring outcome
are time-consuming and labor intensive.
Methods: Bryn Mawr Hospital is a 335-bed community teach-
inghospital that converted to an electronicmedical record (EMR) in
July 2007 and instituted computerized order entry (CPOE) in June
2010. In September 2010, an antimicrobial SP was developed with
one infectious diseases physician and one pharmacist. Selected
broad spectrum and/or costly antibiotic usages are reviewed daily.
The EMR allowed rapid evaluation of antibiotic use from a cen-
tral location. Actions were based on formulary restriction of agents
and institutional practice guidelines. Data was collected on cases
reviewed, interventions necessary, days of therapy (DOT) per 1000
patient-days, cost reduction, and impact on institutional antibi-
ograms.
Results: Initially, about 40% of interventions resulted in dis-
continuation of targeted antibiotic, 30% of cases were deferred
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ending culture results, and 30% of antimicrobial prescribing was
ot changed. After one year, the respective percentages were:
0%, 20%, and 30%. Incorporating educational conferences into the
rogram, decreased cases requiring review somewhat. However,
eriodic increases related to housestaff rotations and medical staff
hanges were noted. Coordination with microbiology laboratory,
ospital infection control, and quality assurance groups aided in
ompliance with guidelines. During the initial year, DOT per 1000
atient-days decreased by 36% for targeted antibiotics with a cost-
avings of $277,000 (30% of total antimicrobial budget).
Conclusion: A hospital antimicrobial SP can use EMR to rapidly
ather information from multiple areas allowing assessment of
ppropriate antimicrobial use. Currently plans are to expand the
ducational portion of the program and institute point-of-service
eedback via CPOE. It is hoped that assessment of program effec-
iveness can be improved and impact on the hospital antibiogram
etermined. Hospitals considering antimicrobial stewardship pro-
rams and/or implementing an EMR can take advantage of many
f our ﬁndings.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.632
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valuation of vancomycin dosing in overweight and obese
atients with a creatinine clearance less than 60 milliliters per
inute
. Spears ∗, T. Dang, J. Eckert, J. Schmeding
Saint Joseph Hospital, Tampa, Fl, USA
Background: Due to conﬂicting data from pharmacokinetic
tudies in obese patients regarding dosing weight, there is uncer-
aintywhether actual bodyweight is the appropriate dosingweight
o use in this patient population. The goal of this study is to evaluate
hether actual body weight or less than actual body weight (ideal
r adjusted) is a better predictor of the target vancomycin serum
oncentration in overweight and obese patients with a creatinine
learance (CrCl) less than 60 ml/min.
Methods: A vancomycin usage report was used to identify
atients on vancomycin between December 2010 and July 2011.
retrospective chart review using the health system’s electronic
edical record was performed to identify adult patients 18 years
f age or older with a body mass index (BMI) greater than 24.9
g/m2 (overweight) or BMI greater than 29.9 kg/m2(obese) and
rCl less than 60 ml/min, who received vancomycin treatment for
ore than48hours andhadat least one serumvancomycin concen-
ration drawn. The vancomycin dose was reviewed to determine if
ctual body weight or less than actual body weight was used to
alculate the initial dose. Patients whose dosing weight could not
learly be determined to be either actual or less than actual were
xcluded in addition to dialysis or pregnant patients. The percent-
ge of patients who had a serum vancomycin concentration within
he target range for the indicated diagnosis when dosed based on
ctual body weight versus when initially dosed based on less than
ctual body weight was determined.
Results: A total of 83 patients were identiﬁed. Most patients
ere dosed based on less than actual body weight (n =68,82%). Ofhese, 36 (53%) had a therapeutic, 15 (22%), had a subtherapeutic,
nd 17 (25%) had a supratherapeutic vancomycin serum concen-
ration. Of these patients dosed on actual body weight (n =15,18%),fectious Diseases 16S (2012) e317–e473 e445
1 (7%) had a therapeutic, 5 (33%) had a subtherapeutic, and 9 (60%)
had a supratherapeutic vancomycin serum concentration.
Conclusion: Supratherapeutic vancomycin serum concentra-
tions may be preventable when using less than actual body weight
to dose vancomycin in overweight and obese patients with a crea-
tinine clearance less than 60ml/min.
http://dx.doi.org/10.1016/j.ijid.2012.05.633
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Ignorance: a blessing or a curse-awareness among Indian physi-
cians on NDM-1 and its impact on antibiotic selection
D. Sureshkumar1,∗, J. Hemalatha2, A. Ghafur3
1 Apollo Hospital, Chennai, India
2 Infectious Disease Education and Research Foundation, Chennai, TN,
India
3 Apollo Hospitals, Chennai, India
Background: Lack of awareness on the seriousness of antimi-
crobial resistance is an important contributing factor to its global
dissemination. Recent publications on the NDM-1(New Delhi
metallo- betalactamase -1) producing bacteria did indeed create
a stir among the public, medical community and the media. But the
level and depth of awareness among Indian physicians on this new
resistance mechanism is not yet studied. The objective of the study
was to assess physicians’ awareness regarding NDM-1 producing
bacteria and toevaluate their understandingon theantibiotic selec-
tion, in the era of NDM-1.
Methods: The cross-sectional survey was carried out among
physicians afﬁliated to various hospitals in South India, using struc-
tured, anonymous questionnaire (regarding NDM-1 awareness,
preferred antibiotic for hospitalized patients in the current era)
between December 2011 and January 2012.
Results: A total of 114 physicians completed the questionnaire.
Only 29.13% (31/114) of the participants were aware on both the
presence of the new resistance mechanism and its name. One ﬁfth
of the participants (22/114-19.29%)were neither aware of the pres-
ence of a new resistance mechanism in the continent nor know the
name NDM-1. However, majority (61/114 -53.50%) of the partici-
pants were aware about the presence but not the name. Nearly half
of the physicians (15/31) who were aware about NDM-1 preferred
either carbapenemor abetalactam-betalactamse inhibitor (BL-BLI)
combination as empirical therapy for treating sepsis in hospitalised
patients, but physicians who were unaware about the NDM-1, two
(9.09% - 2/22) preferred BL-BLI and none chose carbapenem. Col-
istin or tigecycline was not a choice of any of the participants.
Conclusion: Despite the NDM-1 controversy, half of the partici-
pants haven’t heard the name NDM-1, even though they are aware
of a new resistance mechanism in the Indian subcontinent. One
ﬁfth of the doctors aren’t even aware of this new resistance mech-
anism. None of the participant chose colistin/tigecycline to treat
sepsis in the NDM-1 era. Urgent measures should be undertaken to
educate Indian physicians on basics of antimicrobial resistance andhttp://dx.doi.org/10.1016/j.ijid.2012.05.634
